Showing results (1211-1220 of 1,351) with videos related to

Sort By:
Pageof 136
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2022
Model soups improve performance of dermoscopic skin cancer classifiersRoman C Maron, Achim Hekler, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2022
Explainable artificial intelligence in skin cancer recognition: A systematic reviewKatja Hauser, Alexander Kurz, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2020
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. TreatmentAlexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2024
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2021
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanomaAlexander Mm Eggermont, Andrey Meshcheryakov, Victoria Atkinson, et al.
Lancet (London, England)|June 4, 2015
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trialGeorgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Annals of Surgical Oncology|June 8, 2011
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter databaseRichard L White, Gregory D Ayers, Virginia H Stell, et al.
Plos One|January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab networkCaroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2024
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Pageof 136